Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Postmarket transformation roadmap coming soon

This article was originally published in The Gray Sheet

Executive Summary

The Center for Devices & Radiological Health is nearing completion of a detailed strategy to revamp the postmarket device safety program, according to Office of Surveillance and Biometrics Director Susan Gardner. The plan will include a prioritized list of areas where the device center aims to update and enhance its surveillance techniques. CDRH announced the postmarket transformation initiative in January, following an internal review of the current framework (1"The Gray Sheet" Jan. 23, 2006, p. 5). While there is no deadline for the document, Gardner says the team hopes to complete it by the end of June...

You may also be interested in...



FDA Unveils Medical Device “Postmarket Transformation”

FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel